| 1 |
31379119 | Diabetes drugs and stroke risk: Intensive versus conventional glucose-lowering strategies, and implications of recent cardiovascular outcome trials. | 2020 Jan |
1 |
| 2 |
30515958 | Pharmacogenetics of type 2 diabetes mellitus, the route toward tailored medicine. | 2019 Mar |
1 |
| 3 |
31741435 | A Review of Cardiovascular Outcomes Trials of Glucose-Lowering Therapies and Their Effects on Heart Failure Outcomes. | 2019 Dec 15 |
1 |
| 4 |
28418203 | Effectiveness of vildagliptin as add-on to metformin monotherapy among uncontrolled type 2 diabetes mellitus patients in a real-world setting. | 2018 Jan |
1 |
| 5 |
29549573 | Pharmacovigilance Evaluation of the Association Between DPP-4 Inhibitors and Heart Failure: Stimulated Reporting and Moderation by Drug Interactions. | 2018 Apr |
1 |
| 6 |
29943442 | Calendar time as an instrumental variable in assessing the risk of heart failure with antihyperglycemic drugs. | 2018 Aug |
2 |
| 7 |
30518618 | Incretin based drugs and risk of cholangiocarcinoma among patients with type 2 diabetes: population based cohort study. | 2018 Dec 5 |
1 |
| 8 |
26982210 | Important differences in the durability of glycaemic response among second-line treatment options when added to metformin in type 2 diabetes: a retrospective cohort study. | 2016 |
1 |
| 9 |
27321330 | Triple therapy combinations for the treatment of type 2 diabetes - A network meta-analysis. | 2016 Jun |
1 |
| 10 |
27627081 | [The effect of antidiabetic treatment on the bone of patients with type 2 diabetes]. | Fall 2016 |
1 |
| 11 |
26173919 | Clinical pharmacology of dipeptidyl peptidase 4 inhibitors indicated for the treatment of type 2 diabetes mellitus. | 2015 Oct |
1 |
| 12 |
30298777 | Potential for dipeptidyl peptidase-4 inhibitor and sodium glucose cotransporter 2 inhibitor single-pill combinations. | 2015 May |
1 |
| 13 |
22324384 | Dipeptidyl peptidase-4 inhibitors: 3 years of experience. | 2012 Apr |
1 |
| 14 |
22512582 | Novel serine protease dipeptidyl peptidase IV inhibitor: alogliptin. | 2012 Nov |
1 |
| 15 |
22025784 | Dipeptidyl peptidase-4 inhibitors and bone fractures: a meta-analysis of randomized clinical trials. | 2011 Nov |
1 |
| 16 |
20388897 | Effect of noninsulin antidiabetic drugs added to metformin therapy on glycemic control, weight gain, and hypoglycemia in type 2 diabetes. | 2010 Apr 14 |
1 |
| 17 |
20690781 | Dipeptidylpeptidase-4 inhibitors (gliptins): focus on drug-drug interactions. | 2010 Sep |
2 |
| 18 |
20876838 | Managing hyperglycemia in patients with type 2 diabetes mellitus: rationale for the use of dipeptidyl peptidase-4 inhibitors in combination with other oral antidiabetic drugs. | 2010 Sep |
1 |
| 19 |
19748066 | Clinical results of treating type 2 diabetic patients with sitagliptin, vildagliptin or saxagliptin--diabetes control and potential adverse events. | 2009 Aug |
1 |
| 20 |
18333888 | The dipeptidyl peptidase-4 inhibitor PHX1149 improves blood glucose control in patients with type 2 diabetes mellitus. | 2008 Apr |
1 |